Navigation Links
Genetic testing may help select women with ER+ breast cancer for extended hormone therapy
Date:3/19/2014

the next five years: 10.3% versus 12.3%."

The researchers say that their results show that, despite similar overall recurrence rates for patients with ER+ tumours between the first five years and the next five to ten years, there were important differences between groups of tumours with different genetic expression profiles.

"Importantly, HER2- tumours that are very sensitive to oestrogen are usually considered to be relatively low risk, yet these were the tumours that showed an increase in recurrence after five years, which coincided with the cessation of adjuvant hormonal therapy," said Prof Dowsett. "It is commonly thought that the reduction in recurrence achieved by five years of endocrine therapy 'carries-over' into the next five years. Our results suggest this effect may differ markedly between different groups of ER+ tumours. We need to do more detailed analyses on large numbers of tumours to find out if this is the case."

He said the results also suggested a way in which methods of predicting recurrence using genetic signatures may be improved. "Better predictors of recurrence than the OncotypeDX and others currently being used should be possible based on the different recurrence rates of different groups of tumours and their different sensitivity to endocrine therapy." He and his colleagues are already working to see if they achieve this.

"We are already testing over 900 tumours from the ATAC trial to see if we can identify the oestrogen-sensitive tumours better than by the genes in the Oncotype test. This will allow us to see whether, using the knowledge from this work, we can indeed create better predictors of recurrence both for the first five years and subsequent years after diagnosis," he said.

The findings could change clinical practice: women with HER2-, high oestrogen signalling breast cancer might be considered for adjuvant hormone therapy that is extended to ten years. However, the results need to b
'/>"/>

Contact: Emma Mason
wordmason@mac.com
ECCO-the European CanCer Organisation
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Genetic test could improve colon cancer screening
2. Sea anemone is genetically half animal, half plant
3. Fly meeting to spotlight research advances in genetics
4. Rice synthetic biologists shine light on genetic circuit analysis
5. Sudden cardiac death: Genetic disease ARVC more common than hitherto assumed
6. CHOP researcher finds more genetic signals linking weight and heart health risk factors
7. New tool to unlock genetics of grape-growing
8. Researchers at LSTM crack the genetic secret of mosquito resistance to DDT and ITNs
9. New study shows a genetic link between feeding behavior and animal dispersal
10. Compound improves cardiac function in mice with genetic heart defect, MU study finds
11. Genetics linked to children viewing high amounts of violent media
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2015)... , June 23, 2015  Crossmatch™, a ... authentication solutions, today announced enhanced functionality of its ... solution.  The enhancements build on the native ... DigitalPersona Altus platform and provide expanded mobile ... In today,s environment of increasing cyber-attacks ...
(Date:6/18/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... mobile commerce market announces that its Wocket® smart wallet will ... the Mark", scheduled to air on WABC Radio (am770) in ... . The broadcast air- time for the ... EST. NXT-ID, Inc.,s CEO Gino Pereira will be ...
(Date:6/17/2015)... Germany , June 17, 2015 ... QIA) today launched new Investigator ® STR assay kits ... the United States . The new genetic fingerprint ... genomic markers (short tandem repeats or STRs) for DNA matching. ... the quality of DNA in each sample, a novel QIAGEN ...
Breaking Biology News(10 mins):Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5
... Feb. 3, 2010 -- Invasive plants could become even more ... new analysis of data stretching back more than 150 years. ... Harvard University scientists who conducted the study say that non-native ... of climate change because they,re better able to adjust the ...
... NY, February 2, 2010 Videourology is the first ... and micro-invasive video demonstrations of the latest techniques and ... is Part B of the respected Flagship publication ... Liebert, Inc. ( www.liebertpub.com ), and is available free ...
... WASHINGTON, DC (February 2, 2010) Pamphlets detailing the ... up in an unexpected location: your child,s pediatrician,s office. ... Control and Prevention (CDC), one in five American teens ... disease in adulthood. With heart health front-and-center this ...
Cached Biology News:Invasive plants are beneficiaries of climate change in Thoreau's woods 2Groundbreaking Videourology journal launched by Mary Ann Liebert, Inc. 2Lifestyle changes for teens critical in light of research about teens' heart disease risk 2
(Date:7/1/2015)... PALO ALTO, Calif. , July 1, 2015 ... company focused on the development of groundbreaking drugs ... sclerosis (ALS), announced today that Robert G. ... Research Center at Sutter Health,s California Pacific Medical ... from The ALS Association for $1.5 million to ...
(Date:7/1/2015)... Isagenix International, a leading global health and ... Silver, and three Bronze Stevie® Awards at the 2015 ... Chicago this month.The American Business Awards ... in the U.S. "Winning is a ... leaders, cultivating talent, creating a unified team, and crafting ...
(Date:7/1/2015)... , July 1, 2015 InferMed ... technology will ... evidence-based clinical s olutions suite   ... and medical information products and services, announced today the acquisition ... decision support (CDS) technology company. InferMed,s Arezzo technology ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... sterilized to combat pathogen transmission. CTI’ new Medical Joysticks have an impermeable ... devices now have an operator control device that will increase healthcare worker safety ...
Breaking Biology Technology:Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Isagenix Earns Nine American Business Awards 2Isagenix Earns Nine American Business Awards 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 2Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 4Sanitized Medical Joysticks for a Safer and Healthier Work Environment 2
... , a Wisconsin company specializing in functional Magnetic ... honored with a Wisconsin Small Business Innovation Award ... a Phase I Small Business Innovation Research (SBIR) ... begin the development and validation of fMRI-based biomarkers ...
... up a pizza the other night. I ran into Doug ... the massive digital image library. Doug is now the ... digital pictures. , ,If, like me, youve found that by the ... moment for sharing has passed, then youll like ZoomAlbum. This ...
... today approved GE Healthcare's Lunar iDXA, a ... detect, diagnose and monitor treatment of osteoporosis, a disease ... fracture, more accurately and earlier in the disease process. ... composition and ascertain fat distribution. , ,In addition, ...
Cached Biology Technology:ZoomAlbum operates virtually 2ZoomAlbum operates virtually 3
Mouse monoclonal antibody raised against a partial recombinant ZNF167. NCBI Entrez Gene ID = ZNF167...
... antibody raised against a partial ... Immunogen: SLC22A3 (NP_068812, 90 ... recombinant protein with GST tag. ... NM_021977 ...
...
... Deletion Cosmid Cloning Kit enables you to ... and unbiased primary cosmid library of genomic ... deletion sublibraries. High efficiency cosmid library construction ... kit protocols. First, genomic DNA is randomly ...
Biology Products: